Does early phase study enrollment for pediatric oncology patients have an impact on symptom burden and quality of life (QOL)? A national Canadian study report.

10023 Background: There are few therapeutic options for pediatric patients with relapsed or refractory cancers. The impact of early phase trial enrolment on the quality of life (QOL) and symptom burden in this patient population is unknown. We hypothesized that this information could inform future clinical trial design and would be of value to clinicians, patients and their families. The primary aim was to determine if those enrolled on a …